Shamee Bhattacharjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shamee Bhattacharjee has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Deba Prasad Mandal
Department of Zoology, West Bengal State University, Kolkata, West Bengal, 700126, India
5 shared publications Kartick Patra
Department of Zoology, West Bengal State University, Berunanpukuria, Malikapur, North-24 Parganas, Barasat, Kolkata, 700126, West Bengal, India
2 shared publicationsSamarjit Jana
Department of Zoology, West Bengal State University, Berunanpukuria, Malikapur, North-24 Parganas, Barasat, Kolkata, 700126, West Bengal, India
2 shared publicationsAnupam Das Talukdar
Department of Life Science and Bioinformatics, Assam University, Silchar-788011, India
1 shared publicationArnab Chatterjee
Department of Chemistry, The University of Burdwan, Burdwan, India
1 shared publicationArnab Sarkar
Department of Zoology, West Bengal State University, Kolkata-700126, India
1 shared publication
Latest Publications
- 30 April 2021
- Published by Springer Nature in Journal of Chemical Sciences
- Vol. 133 (2) , 1-10
Synthesis, X-ray structures and cytotoxic effects of a Cu(II)- and a Zn(II) thiosemicarbazones on human epidermoid carcinoma cell A431
- 30 April 2021
- Published by Springer Nature in Journal of Chemical Sciences
- Vol. 133 (2) , 1-10
Synthesis, X-ray structures and cytotoxic effects of a Cu(II)- and a Zn(II) thiosemicarbazones on human epidermoid carcinoma cell A431
- 5 October 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (10) , 9020-9034
Eugenol and capsaicin exhibit anti-metastatic activity via modulating TGF-β signaling in gastric carcinoma
The transforming growth factor-β (TGF-β) signaling is considered to be a key player in gastric cancer metastasis, and the inhibition of the TGF-β/SMAD4 signaling pathway may be a novel strategy for therapeutic interventions in cancer.
- 5 October 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (10) , 9020-9034
Eugenol and capsaicin exhibit anti-metastatic activity via modulating TGF-β signaling in gastric carcinoma
The transforming growth factor-β (TGF-β) signaling is considered to be a key player in gastric cancer metastasis, and the inhibition of the TGF-β/SMAD4 signaling pathway may be a novel strategy for therapeutic interventions in cancer.
- Open Access
- 16 May 2018
- Published by Springer Nature in Discover Nano
- Vol. 13 (1) , 1-16
Evaluating the antimicrobial, apoptotic, and cancer cell gene delivery properties of protein-capped gold nanoparticles synthesized from the edible mycorrhizal fungus Tricholoma crassum
Biosynthesis of gold nanoparticles of distinct geometric shapes with highly functional protein coats without additional capping steps is rarely reported. This study describes green synthesis of protein-coated gold nanoparticles for the first time from the edible, mycorrhizal fungus Tricholoma crassum (Berk.) Sacc. The nanoparticles were of the size range 5–25 nm and of different shapes. Spectroscopic analysis showed red shift of the absorption maxima with longer reaction period during production and blue shift with increase in pH. These were characterized with spectroscopy, SEM, TEM, AFM, XRD, and DLS. The particle size could be altered by changing synthesis parameters. These had potent antimicrobial activity against bacteria, fungi, and multi-drug-resistant pathogenic bacteria. These also had inhibitory effect on the growth kinetics of bacteria and germination of fungal spores. These showed apoptotic properties on eukaryotic cells when tested with comet assays. Moreover, the particles are capped with a natural 40 kDa protein which was utilized as attachment sites for genes to be delivered into sarcoma cancer cells. The present work also attempted at optimizing safe dosage of these nanoparticles using hemolysis assays, for application in therapy. Large-scale production of the nanoparticles in fermentors and other possible applications of the particles have been discussed.
- 16 May 2018
- Published by Springer Nature in Discover Nano
- Vol. 13 (1) , 1-16
Open AccessEvaluating the antimicrobial, apoptotic, and cancer cell gene delivery properties of protein-capped gold nanoparticles synthesized from the edible mycorrhizal fungus Tricholoma crassum
Biosynthesis of gold nanoparticles of distinct geometric shapes with highly functional protein coats without additional capping steps is rarely reported. This study describes green synthesis of protein-coated gold nanoparticles for the first time from the edible, mycorrhizal fungus Tricholoma crassum (Berk.) Sacc. The nanoparticles were of the size range 5–25 nm and of different shapes. Spectroscopic analysis showed red shift of the absorption maxima with longer reaction period during production and blue shift with increase in pH. These were characterized with spectroscopy, SEM, TEM, AFM, XRD, and DLS. The particle size could be altered by changing synthesis parameters. These had potent antimicrobial activity against bacteria, fungi, and multi-drug-resistant pathogenic bacteria. These also had inhibitory effect on the growth kinetics of bacteria and germination of fungal spores. These showed apoptotic properties on eukaryotic cells when tested with comet assays. Moreover, the particles are capped with a natural 40 kDa protein which was utilized as attachment sites for genes to be delivered into sarcoma cancer cells. The present work also attempted at optimizing safe dosage of these nanoparticles using hemolysis assays, for application in therapy. Large-scale production of the nanoparticles in fermentors and other possible applications of the particles have been discussed.
- 15 June 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (70) , 56549-56559
Antitumor potential of anethole singly and in combination with cyclophosphamide in murine Sarcoma-180 transplantable tumor model
The clinical outcome of chemotherapy in cancer treatment is limited due to severe side effects. There has been a mixed response in experimenting with combinations of conventional chemotherapy with dietary agents to improve the therapeutic outcome. This study is aimed to explore the anti-tumor potential of a spice-derived phytochemical, anethole singly and in combination with cyclophosphamide. Various doses of anethole (10, 20 and 40 mg kg−1) were administered orally on alternate days to Sarcoma-180 solid tumor bearing Swiss albino mice on appearance of palpable tumor. Cyclophosphamide (100 mg kg−1) was injected into anethole treated or untreated tumor bearing mice for 3 consecutive days before sacrifice. Results demonstrated that anethole and cyclophosphamide, singly as well as in combination, reduced tumor load to a significant extent. Cell cycle analysis revealed that cyclophosphamide and cyclophosphamide+anethole exhibited significantly more tumoricidal activity than anethole alone. AnnexinV/PI assay suggested that necrosis was the principal means of tumor reduction when cyclophosphamide was used alone or in combination contrasting to the induction of apoptosis in anethole-treated groups. The necrotic cell death was also reflected in tumor histology. Although no additive effect in tumor reduction was observed with combinatorial treatment, use of anethole was instrumental in reducing the side-effects namely myelosuppression, hepatotoxicity and urotoxicity of cyclophosphamide treatment. The hepatoprotective effect of anethole was further proven by its ability to reduce CCl4 induced hepatotoxicity. This study indicates that anethole pre-treatment protected the bone marrow, liver and urinary bladder from the adverse toxicity of cyclophosphamide without interfering with its anticancer effect.
- 15 June 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (70) , 56549-56559
Antitumor potential of anethole singly and in combination with cyclophosphamide in murine Sarcoma-180 transplantable tumor model
The clinical outcome of chemotherapy in cancer treatment is limited due to severe side effects. There has been a mixed response in experimenting with combinations of conventional chemotherapy with dietary agents to improve the therapeutic outcome. This study is aimed to explore the anti-tumor potential of a spice-derived phytochemical, anethole singly and in combination with cyclophosphamide. Various doses of anethole (10, 20 and 40 mg kg−1) were administered orally on alternate days to Sarcoma-180 solid tumor bearing Swiss albino mice on appearance of palpable tumor. Cyclophosphamide (100 mg kg−1) was injected into anethole treated or untreated tumor bearing mice for 3 consecutive days before sacrifice. Results demonstrated that anethole and cyclophosphamide, singly as well as in combination, reduced tumor load to a significant extent. Cell cycle analysis revealed that cyclophosphamide and cyclophosphamide+anethole exhibited significantly more tumoricidal activity than anethole alone. AnnexinV/PI assay suggested that necrosis was the principal means of tumor reduction when cyclophosphamide was used alone or in combination contrasting to the induction of apoptosis in anethole-treated groups. The necrotic cell death was also reflected in tumor histology. Although no additive effect in tumor reduction was observed with combinatorial treatment, use of anethole was instrumental in reducing the side-effects namely myelosuppression, hepatotoxicity and urotoxicity of cyclophosphamide treatment. The hepatoprotective effect of anethole was further proven by its ability to reduce CCl4 induced hepatotoxicity. This study indicates that anethole pre-treatment protected the bone marrow, liver and urinary bladder from the adverse toxicity of cyclophosphamide without interfering with its anticancer effect.
- 1 January 2012
- Published by Begell House Inc. Publishers in Journal of Environmental Pathology, Toxicology and Oncology
- Vol. 31 (3) , 273-283
Angiogenesis Modulation-The "Spice Effect"
Spices have been used as flavoring agents since antiquity. Extensive research throughout the world has indicated that various phytochemicals present in spices play a critical role in the prevention and/or cure of several chronic diseases. Angiogenesis, the formation of new blood vessels, is regulated by a finely balanced equilibrium between pro- and anti-angiogenic factors. Any shift in this balance is linked to a wide range of human disorders. Experimental evidences suggest that anti- or pro-angiogenic strategies can contribute to the therapy of such disorders. The clinical benefits of the U.S. FDA-approved drugs that target angiogenesis are relatively modest due to their high toxicity and exorbitant cost. Therefore, there has been a renewed interest in identifying natural food sources for the development of novel and safer angiogenesis targeting agents. In this article, we discuss those dietary spices and their phytochemicals that have been experimentally found to target the angiogenic pathway.
- 1 January 2012
- Published by Begell House Inc. Publishers in Journal of Environmental Pathology, Toxicology and Oncology
- Vol. 31 (3) , 273-283
Angiogenesis Modulation-The "Spice Effect"
Spices have been used as flavoring agents since antiquity. Extensive research throughout the world has indicated that various phytochemicals present in spices play a critical role in the prevention and/or cure of several chronic diseases. Angiogenesis, the formation of new blood vessels, is regulated by a finely balanced equilibrium between pro- and anti-angiogenic factors. Any shift in this balance is linked to a wide range of human disorders. Experimental evidences suggest that anti- or pro-angiogenic strategies can contribute to the therapy of such disorders. The clinical benefits of the U.S. FDA-approved drugs that target angiogenesis are relatively modest due to their high toxicity and exorbitant cost. Therefore, there has been a renewed interest in identifying natural food sources for the development of novel and safer angiogenesis targeting agents. In this article, we discuss those dietary spices and their phytochemicals that have been experimentally found to target the angiogenic pathway.